Indirect Spectrophotometric Determination of Tolterodine Tartrate in Pure and Pharmaceutical Preparations

被引:5
作者
Fraihat, Safwan M. [1 ]
Khatib, Hatem S. [2 ]
机构
[1] Univ Jordan, Hamdi Mango Ctr Sci Res, Amman 11942, Jordan
[2] Univ Jordan, Coll Pharm, Amman 11942, Jordan
关键词
Tolterodine tartrate; Spectrophotometry; Ce(IV); N-Bromosuccinimide; Pharmaceuticals; TARTARATE; PLASMA;
D O I
10.14233/ajchem.2013.13210
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Two simple, accurate, sensitive and economical procedures for the estimation of tolterodine tartrate (TOL) both in pure and in pharmaceutical formulations have been developed. The first method (A) was based on the oxidation of the studied drug by a known excess of cerium(IV) as an oxidizing agent and subsequent determination of unreacted oxidant by reacting it with (methylene blue) dye, while the second method (B) involved N-bromosuccinimide (NBS) as an oxidant and (indigo) dye. The absorbance values were determined at 660 and 610 nm, respectively. The reacted oxidant corresponds to the drug content. Regression analysis of Beer-Lambert plots showed good correlations in the concentration ranges 5-18 and 38-80 mu g/mL for methods A and B, respectively. The molar absorptivity, Sandell sensitivity, detection and quantification limits were calculated. The optimum reaction conditions and other analytical parameters were evaluated. The proposed methods were applied to the determination of tolterodine tartrate in pharmaceutical formulations. The results have demonstrated that the methods are equally accurate and reproducible as the official methods.
引用
收藏
页码:1887 / 1890
页数:4
相关论文
共 18 条
[1]  
Beibei Z., 2005, J CHROMATOGR B, V82, P492
[2]   Sonic spray ionization interface for liquid chromatography-mass spectrometry [J].
Björkman, HT ;
Edlund, PO ;
Jacobsson, SP .
ANALYTICA CHIMICA ACTA, 2002, 468 (02) :263-274
[3]  
Dwibhashyam V. S, 2009, J PHARM SCI TECHNOL, V63, P234
[4]  
Jan M., 2009, J CHROMATOGR B, V877, P968
[5]  
Lili Z., 2001, J PHARM BIOMED ANAL, V27, P541
[6]   Development and validation of a new analytical method for the determination of related components in tolterodine tartarate using LC [J].
Madhavi, A. ;
Reddy, G. S. ;
Suryanarayana, M. V. ;
Naidu, A. .
CHROMATOGRAPHIA, 2008, 68 (5-6) :399-407
[7]   Thorough QT study with recommended and supratherapeutic doses of tolterodine [J].
Malhotra, B. K. ;
Glue, P. ;
Sweeney, K. ;
Anziano, R. ;
Mancuso, J. ;
Wicker, P. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) :377-385
[8]  
Nanda R., 2009, RES J PHARM TECHNOL, V23, P12
[9]  
Nanda RK, 2009, INT J PHARM TECH RES, V1, P420
[10]   Determination of tolterodine and the 5-hydroxymethyl metabolite in plasma, serum and urine using gas chromatography mass spectrometry [J].
Palmer, L ;
Andersson, L ;
Andersson, T ;
Stenberg, U .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 16 (01) :155-165